Citations

Showing 10 of 108119 citations.

Patients' and physicians' risk-benefit trade-off preferences for metastatic colorectacl cancer treatments.
González, Juan Marcos , Morlock, Robert , Ogale, Sarika, Sommer, Nicolas, Posner, Joshua, Grothey, Axel, Gonzalez Sepulveda, Juan Marcos

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3591-3591

10.1200/jco.2015.33.15_suppl.3591 Get It

Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).
Wilcox, Ryan Eldredge, Foster, Nathan R. , Meyers, Jeffrey P., Goldberg, Richard M. , Nair, Suresh , Shields, Anthony F. , Chan, Emily , Kahlenberg, Morton S., Shi, Qian , Sinicrope, Frank A. , Sargent, Daniel J. , Gill, Sharlene , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3590-3590

10.1200/jco.2015.33.15_suppl.3590 Get It

Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) receiving adjuvant chemotherapy: Results from NCCTG N0147 (Alliance).
Foster, Nathan R. , Grothey, Axel, Chan, Emily , Shields, Anthony F. , Goldberg, Richard M. , Kahlenberg, Morton S., Singh, Preet Paul , Shi, Qian , Nair, Suresh, Gill, Sharlene , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3531-3531

10.1200/jco.2015.33.15_suppl.3531 Get It

Comprehensive multiplatform biomarker analysis of 212 anal squamous cell carcinomas.
Wang, Jue , Arguello, David, Millis, Sherri Z. , Gatalica, Zoran , Hálfdánarson, Þorvarður R. , Halfdanarson, Thorvardur R , Boland, Patrick M. , Reddy, Sandeep K. , Meyer, Joshua E.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3519-3519

10.1200/jco.2015.33.15_suppl.3519 Get It

Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA).
Smyrk, Thomas C. , Harrington, Susan M. , Pedersen, Katrina S. , McWilliams, Robert R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3619-3619

10.1200/jco.2015.33.15_suppl.3619 Get It

A phase Ib study of BBI608 in combination with FOLFIRI with and without bevacizumab in patients (pts) with advanced colorectal cancer (CRC).
Jonker, Derek J. , O’Neil, Bert H. , Hálfdánarson, Þorvarður R. , Li, Youzhi , Borodyansky, Laura, Li, Chiang, Halfdanarson, Thorvardur R , Hubbard, Joleen M. , Grothey, Axel

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3616-3616

10.1200/jco.2015.33.15_suppl.3616 Get It

Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the CORRECT trial who had progression-free survival (PFS) longer than 4 months.
Grothey, Axel, Humblet, Yves, Mineur, Laurent , Adenis, Antoine , Lenz, Heinz‐Josef , Goldberg, Richard M. , Wagner, Andrea, Falcone, Alfredo , Bouché, Olivier , Tabernero, Josep , Yoshino, Takayuki , Xu, Lei , Wagner, Andrea, Cutsem, Eric Van

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e14579-e14579

10.1200/jco.2015.33.15_suppl.e14579 Get It

Phase I, first-in-human trial of LV305 in patients with advanced or metastatic cancer expressing NY-ESO-1.
Somaiah, Neeta , Block, Matthew S. , Hwu, Patrick , Jones, Robin L. , Gnjatic, Sacha , Lu, Hailing , Hsu, Frank J., Gnjatic, Sacha , Jones, Robin L , Kim, Joseph W. , Shapiro, Geoffrey I. , Hwu, Patrick , Eder, Joseph P. , Pollack, Seth M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3021-3021

10.1200/jco.2015.33.15_suppl.3021 Get It

First-in-human study assessing safety and tolerability of REGN1979, a novel CD20xCD3 bispecific antibody, in patients with CD20+ B-cell malignancies previously treated with anti-CD20 therapy.
Brownstein, Carrie , Adriaens, Lieve, Ansell, Stephen M. , Patel, Snehal G. , Kostić, Ana , Trail, Pamela A. , Lowy, Israel , Kohrt, Holbrook Edwin, Bannerji, Rajat , Chavez, Julio C , Levy, Ronald , Advani, Ranjana H.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS3089-TPS3089

10.1200/jco.2015.33.15_suppl.tps3089 Get It

Phase 1 study of the folic acid (FA) and tubulysin B hydrazide (TubBH) small molecule drug conjugate (SMDC) EC1456 in patients (pts) with advanced cancers (CA).
Matei, Daniela, Sachdev, Jasgit C. , Klein, Patrick , Burgess, Shelly, Clark, Romnee, Ramanathan, Ramesh K., Harb, Wael A., Matei, Daniela, Edelman, Martin J. , Rao, Satish B. , Morris, Elizabeth A.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2551-2551

10.1200/jco.2015.33.15_suppl.2551 Get It